Shutterstock
New legislation and regulatory changes are causing shifts within the inhaled drug delivery market. By updating pressurised metered dose inhaler (pMDI) design and formulations, pharmaceutical companies can stay ahead in the changing market landscape. Ross Errington, Head of Drug Product Development at Recipharm, explores how evolving pMDIs can future-proof inhaled drug delivery.